Showing results (121-130 of 186) with videos related to
Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretionD L Trump, J L Grem, K D Tutsch, et al.Molecular Pharmacology|August 1, 1995
Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cellsJ L Grem, F Geoffroy, P M Politi, et al.Investigational New Drugs|July 30, 1999
PALA versus streptozotocin, doxorubicin, and MeCCNU in the treatment of patients with advanced pancreatic carcinomaR S Witte, L M Ryan, A J Schutt, et al.Cancer|December 1, 1991
Cancer control and the older person. Issues in treatmentL Balducci, T Ades, P P Carbone, et al.Cancer Treatment Reports|December 1, 1987
Phase I study of taxol administered as a short i.v. infusion daily for 5 daysJ L Grem, K D Tutsch, K J Simon, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Bioavailability study of oral liquid and tablet forms of alpha-difluoromethylornithineP P Carbone, J A Douglas, J Thomas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinomaJ L Grem, N McAtee, R F Murphy, et al.Cancer Research|April 1, 1989
Methotrexate and dipyridamole combination chemotherapy based upon inhibition of nucleoside salvage in humansJ K Willson, P H Fischer, S C Remick, et al.Cancer|October 1, 1978
Diffuse well-differentiated lymphocytic lymphoma (DLWD): response and survivalF Icli, E Z Ezdinli, W Costello, et al.British Journal of Cancer|March 1, 1977
Assessment of response to therapy in advanced breast cancerJ L Hayward, P P Carbone, J C Heusen, et al.Pageof 19